CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions		Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2019		$ 2,476	$ (5)	$ 0	$ 26	$ 1,108	$ 2,178	$ (5)	$ (836)
Beginning balance (in shares) at Dec. 31, 2019					53,278,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)		(103)					(122)		19
Common stock dividends declared and paid		(121)					(121)
Common stock issued under employee stock option and stock purchase plans and other (in shares)					1,091,000
Common stock issued under employee stock award and stock purchase plans and other		8			$ 1	7
Common stock repurchases ( in shares)					(637,000)
Common stock repurchases		(29)				(12)	(17)
Share-based compensation		30				30
Ending balance at Dec. 31, 2020		2,256		0	$ 27	1,133	1,913		(817)
Ending balance (in shares) at Dec. 31, 2020					53,732,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)		647					519		128
Common stock dividends declared and paid		(125)					(125)
Common stock issued under employee stock option and stock purchase plans and other (in shares)					792,000
Common stock issued under employee stock award and stock purchase plans and other		30				30
Common stock repurchases ( in shares)					(735,000)
Common stock repurchases		(57)				(16)	(41)
Share-based compensation		47				47
Ending balance at Dec. 31, 2021		$ 2,798		0	$ 27	1,194	2,266		(689)
Ending balance (in shares) at Dec. 31, 2021		53,789,036			53,789,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)		$ 760					867		(107)
Common stock dividends declared and paid		(124)					(124)
Common stock issued under employee stock option and stock purchase plans and other (in shares)	[1]				(549,000)
Common stock issued under employee stock award and stock purchase plans and other	[1]	14				14
Common stock repurchases ( in shares)					(6,953,000)
Common stock repurchases		(557)			$ (4)	(62)	(491)
Share-based compensation		46				46
Ending balance at Dec. 31, 2022		$ 2,937		$ 0	$ 23	$ 1,192	$ 2,518		$ (796)
Ending balance (in shares) at Dec. 31, 2022		46,286,664			46,287,000

[1] We reversed the issuance of approximately 1.3 million unvested restricted shares that were administratively recorded as issued, but not released. These shares will be issued and released upon satisfaction of the applicable vesting conditions. The reversal of the shares did not impact earnings per share.